Allergan, Others Appeal £260M Antitrust Fine Over Drug Prices
Drugmaker Allergan and four other pharmaceutical companies have appealed a record £260 million ($357 million) fine from the U.K.'s competition watchdog, saying the regulator was wrong that the companies had market...To view the full article, register now.
Already a subscriber? Click here to view full article